ClinicalTrials.gov
public full text
Public Domain
Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP)
Tumor Derived cell free DNA (cfDNA) is increasingly used in the clinic to obtain genotype information about lung cancer, but its concordance with concurrent tumor-derived sequenced data is not known. The primary objective of this study is to demonstrate the non-inferiority of cfDNA-based versus tumor tissue-based genotyping.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Gene Mutations in Non-Small Cell Lung Cancer Cells#810804
- Early detection and subtyping of gastric cancer: A cell-free DNA fragmentome-based liquid biopsy method.#170651
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer#873612
- The ctDNA-RECIST Trial Part One#901513
- Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer#802048
Record · ID 911061
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive